Study details
Enrolling now
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
Albert Einstein Healthcare Network
NCT IDNCT06225830ClinicalTrials.gov data as of Apr 2026
Target enrollment
24
Study length
about 2.1 years
Ages
18+
Locations
1 site in PA
What this study is about
Researchers are testing if using a robotic device called the Eksobionic Exoskeleton (Esko) can help people with Parkinson's disease improve their walking, balance, and overall quality of life. The trial will involve an eight-week training program with the Esko device, followed by ongoing monitoring to assess its long-term effects.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Eksobionics Eksoskeleton NR
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Gait endurance- 6MWT, Quality of Life- WHOQOL-BREF
Body systems
Neurology